Literature DB >> 7624588

[References for evaluation instruments for quality assurance in rehabilitation--2. The IRES questionnaire for clinical aspects and research].

N Gerdes1, W H Jäckel.   

Abstract

The article presents the comprehensive Indicators of Reha Status (IRES) patient questionnaire that can be used for assessment and outcome measurement in rehabilitation. We explain why the ¿preventive-rehabilitative¿ orientation characteristic of the system of rehabilitation in Germany asks for particularly sensitive instruments as well as for inclusion of certain psychosocial variables. The results of validation studies are presented in some detail. In discussing possible applications of the questionnaire, we concentrate on its use for clinical practice (functional and psychosocial diagnostics, quality assessment). Finally, information is given on how to obtain questionnaires and the special computer programme for data entry and analysis.

Entities:  

Mesh:

Year:  1995        PMID: 7624588

Source DB:  PubMed          Journal:  Rehabilitation (Stuttg)        ISSN: 0034-3536            Impact factor:   1.113


  4 in total

1.  [Anxiety and depression after loss of a lower limb].

Authors:  E Seidel; C Lange; H H Wetz; G Heuft
Journal:  Orthopade       Date:  2006-11       Impact factor: 1.087

2.  Occupational Therapy Interventions Supporting Leisure and Social Participation for Older Adults With Low Vision: A Systematic Review.

Authors:  Julie Ann Nastasi
Journal:  Am J Occup Ther       Date:  2020 Jan/Feb

3.  The assessment of mood at workplace - psychometric analyses of the revised Profile of Mood States (POMS) questionnaire.

Authors:  Matthias Morfeld; Corinna Petersen; Anja Krüger-Bödeker; Sylvia von Mackensen; Monika Bullinger
Journal:  Psychosoc Med       Date:  2007-05-10

4.  [Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness].

Authors:  W Finkenzeller; I Zobel; S Rietz; E Schramm; M Berger
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.